Overview of the treatment of acute lymphoblastic leukemia/lymphoma in children and adolescents - UpToDate
uptodate.com · 349 words · saved by 1 readers
{{configCtrl2.info.metaDescription}}
Treatment of acute lymphoblastic leukemia/lymphoma in children and adolescents INTRODUCTION Acute lymphoblastic leukemia/lymphoma (ALL/LBL) is the most common cancer in children, accounting for nearly one-third of all childhood malignancies. ALL and LBL are considered the same disease, distinguished only by the primary location of the disease and level of bone marrow involvement. Overall survival for children with ALL/LBL is >90 percent and has improved dramatically since the 1980s due, in part, to successive research protocols that improved clinical outcomes while reducing toxicity.…
related reading
- Acute myeloid leukemia: Children and adolescentsuptodate.com
- Acute myeloid leukemia: Children and adolescentsuptodate.com
- Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in childrenuptodate.com
- Childhood leukemia: how a deadly cancer became treatableourworldindata.org
- Initial treatment of acute promyelocytic leukemia in adultsuptodate.com
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adultsuptodate.com
- Hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes in children and adolescentsuptodate.com
- Guidance for Industryfda.gov
- Notionnotion.so
- Classic Hodgkin lymphomapathologyoutlines.com
- Notionnotion.so